Table 1.

The clinicopathological features of 162 patients with glioma.

Parameters	Training set (n = 113)	Validation set (n = 49)	p-value
Sex, No [%]			0.05
Men	67 [59.29]	37 [75.51]
Women	46 [40.71]	12 [24. 49]
Age, No [%]			0.80
≤20	14 [12.39]	7 [14.29]
21–40	32 [28.32]	16 [32.65]
41–60	49 [43.36]	20 [40.82]
≥61	18 [15.93]	6 [12.24]
Grade, No [%]			0.70
I	13 [11.50]	3 [6.12]
II	49 [43.36]	26 [53.06]
III	37 [32.74]	13 [26.53]
IV	14 [12.39]	7 [14.29]
Subtype, No [%]			0.14
Astrocytoma	35 [29.41]	8 [16.33]
Oligodendroglioma	4 [3.36]	2 [4.08]
Ependymoma	1 [0.84]	2 [4.08]
Ganglioglioma	5 [4.20]	2 [4.08]
Glioblastoma	74 [62.18]	35 [71.43]
DFS (months)			0.53
Median (range)	62 (9–113)	63 (6–113)
OS (months)			0.38
Median (range)	84 (9–113)	76 (6–113)